Wary pharma: AstraZeneca sours on UK

The Federal Reserve has raised interest rates for the first time since July 2023. For the central bank’s new chair Kevin Warsh, that decision was a test both of monetary policy and politics. A governor’s election in Okinawa is a boon to Japan’s military ambitions. And why summer ...  عرض المزيد

Is artificial intelligence becoming uncontrollably powerful? Our correspondent analyses whether a pause to breakneck development is possible or feasible. We have entered the new age of the orator. And why cheese is getting more popular in India. Guests and host:Alex Hern, AI writ ...  عرض المزيد

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  عرض المزيد

An AstraZeneca vaccine trial on children gets put on pause while a possible link with rare blood clots is investigated. And former Bank of England governor, Mark Carney, talks climate change, fintech and... should Adam sell his Bitcoin? Today’s Newscast was made by Sam Bonham wit ...  عرض المزيد

AstraZeneca has drawn up plans to break out its China business, and France is challenging a German-led plan to build up Europe’s air defences. Plus, US businesses are cutting back on their investments in diversity and inclusion. 

Mentioned in this p ...

As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ...  عرض المزيد